MarketInOut Stock Screener Log In | Sign Up

Vericel Corp

NASDAQ • Healthcare • Biotechnology • Quote as of 11/16/2026 16:00
Vericel Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,906.66 mln
Float50.42 mln
Earnings Date02/25/2027

EPS

0.64
Stretched

P / E

89.81
Speculative

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.42
Borderline

Relative Strength

99 / 100
Top performer

Debt / Equity

0.24
Very low leverage

Business Description

Vericel Corporation, based in Cambridge, Massachusetts, develops and sells specialized medical treatments using living cells and biological materials. The company offers three main products: a knee cartilage repair treatment, a permanent skin replacement for severe burn patients, and a burn wound cleaning therapy used in both adults and children. Originally founded in 1989 under the name Aastrom Biosciences, Vericel serves healthcare providers across North America in the fields of sports medicine and burn care.

Key Fundamentals

EPS0.64
P/E89.81
ROE9.32
RPS6.37
ROIC8.33
ROA6.81
Interest Cover42.01
EBITDA, mln48.48
EV / EBITDA57.67
EV / EBIT80.33
Revenue, mln324
EV / Revenue8.63

Quote Details

Last 57.48
Change 0.52 (0.91%)
Open 56.85
Volume 972,825
Turnover 55,917,980
Average Volume 909,385

Financial Ratios

Pre-Tax Profit Margin11
Leverage Ratio1.35
Current Ratio5.13
Price / Book7.26
Price / Tangible Book7.35
Price / Cash Flow44.64
Price / Free Cash Flow49.07
Debt / Equity0.24
Price / Sales8.77

Financial Strength

Altman Z-Score13.01
Piotroski F-Score 8 / 9
Beneish M-Score-2.42
Price to Intrinsic Value5.16
Price to Graham Number5.32
Short Ratio9.63
Short % of Float13.55

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.56% 58 / 100   
1 Month 43.23% 99 / 100   
2 Months 29.61% 97 / 100   
6 Months 64.84% 97 / 100   
1 Year 44.28% 91 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog